procainamide has been researched along with Central Hypothyroidism in 2 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shapiro, B | 1 |
| Kollmann, GJ | 1 |
| Heine, WI | 1 |
| Vána, S | 1 |
| Nĕmec, J | 1 |
| Svorcík, C | 1 |
2 other studies available for procainamide and Central Hypothyroidism
| Article | Year |
|---|---|
Pitfalls in the application of digoxin determinations.
Topics: Administration, Oral; Aged; Biopharmaceutics; Calcium; Digoxin; Drug Interactions; Female; Heart Dis | 1975 |
[Use of hypometabolic therapy in an unusual antiarrhythmic indication].
Topics: Arrhythmias, Cardiac; Drug Therapy, Combination; Electrocardiography; Female; Heart Block; Humans; H | 1974 |